Epilepsy encompasses a group of heterogeneous brain diseases that affect more than 50
million people worldwide. Epilepsy may have discernible structural, infectious, metabolic …

Background Epilepsy is one of the most common neurological conditions worldwide. As a
chronic condition, epilepsy imposes a significant burden on people with epilepsy and …

Epilepsy is a brain disease characterized by abnormal electrical activity causing seizures or
unusual behaviour, sensations and sometimes loss of awareness. It carries neurological …

Objectives Collateral damage may occur in epilepsy management during the coronavirus
(COVID‐19) pandemic. We aimed to establish the impact of this pandemic on epilepsy …

Introduction Epilepsy is a serious neurological disorder affecting the quality of life (QoL) of
people with this condition. A survey was conducted in five European countries (France …

This article provides a succinct overview of sex differences in epilepsy and putative
molecular mechanisms underlying sex differences in seizure susceptibility in chemical …

Objective: The objective of the study is to investigate the gender and socioeconomic
disparities in the global burden of epilepsy by prevalence and disability-adjusted life-years …

Flavonoids, a group of natural compounds with phenolic structure, are becoming popular as
alternative medicines obtained from plants. These compounds are reported to have various …

Background Epilepsy and neurocysticercosis (NCC) prevalence estimates in sub-Saharan
Africa are still scarce but show important variation due to the population studied and different …

Introduction The pentylenetetrazol (PTZ)-induced kindling model acts through the
antagonism of central GABA A receptors and is one of the most widely used experimental …